{"id":"https://openalex.org/W4388646403","doi":"https://doi.org/10.3389/fimmu.2023.1331317","title":"Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy","display_name":"Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy","publication_year":2023,"publication_date":"2023-11-13","ids":{"openalex":"https://openalex.org/W4388646403","doi":"https://doi.org/10.3389/fimmu.2023.1331317","pmid":"https://pubmed.ncbi.nlm.nih.gov/38022608","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10679677"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2023.1331317","doi":"https://doi.org/10.3389/fimmu.2023.1331317","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3389/fimmu.2023.1331317","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1331317/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://public-pages-files-2025.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1331317/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048027972","display_name":"Bettina Hoden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bettina Hoden","raw_affiliation_strings":["Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States","institution_ids":["https://openalex.org/I91045830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101542975","display_name":"Yasuhiro Nagai","orcid":"https://orcid.org/0000-0003-1472-4213","observed_orcids":["https://orcid.org/0000-0003-1472-4213"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yasuhiro Nagai","raw_affiliation_strings":["Cancer Research Unit, Sumitomo Pharma Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Unit, Sumitomo Pharma Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023805918","display_name":"Laura Graves Schuettpelz","orcid":"https://orcid.org/0000-0001-6047-3641","observed_orcids":["https://orcid.org/0000-0001-6047-3641"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Laura Schuettpelz","raw_affiliation_strings":["Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079586674","display_name":"Dekai Zhang","orcid":"https://orcid.org/0000-0001-5770-0903","observed_orcids":["https://orcid.org/0000-0001-5770-0903"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dekai Zhang","raw_affiliation_strings":["Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States","institution_ids":["https://openalex.org/I91045830"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023805918","https://openalex.org/A5079586674","https://openalex.org/A5101542975"],"corresponding_institution_ids":["https://openalex.org/I204465549","https://openalex.org/I31591830","https://openalex.org/I91045830"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":null,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":null,"first_page":"1331317","last_page":"1331317"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.8026999831199646,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.8026999831199646,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.19339999556541443,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/toll-like-receptors","display_name":"Toll-like receptors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.734000027179718},{"id":"https://openalex.org/keywords/toll-like-receptor-agonists","display_name":"TLR agonists","score":0.9010000228881836},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7089999914169312},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8479999899864197},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.8349999785423279},{"id":"https://openalex.org/keywords/tlr-targeted-therapy","display_name":"TLR-targeted therapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.527999997138977},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.8379999995231628},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7398466467857361},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6359098553657532},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6218347549438477},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.6117052435874939},{"id":"https://openalex.org/C2778025104","wikidata":"https://www.wikidata.org/wiki/Q408004","display_name":"Toll","level":2,"score":0.58432537317276},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5493365526199341},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46037182211875916},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4139930009841919},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.26319602131843567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21104136109352112}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D051193","descriptor_name":"Toll-Like Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2023.1331317","doi":"https://doi.org/10.3389/fimmu.2023.1331317","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3389/fimmu.2023.1331317","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1331317/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10679677","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10679677","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10679677/pdf/fimmu-14-1331317.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:38022608","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38022608","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:4009b0d8f4f646b59d6330ed590113ed","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4009b0d8f4f646b59d6330ed590113ed","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 14 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2023.1331317","doi":"https://doi.org/10.3389/fimmu.2023.1331317","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3389/fimmu.2023.1331317","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1331317/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388646403.pdf","grobid_xml":"https://content.openalex.org/works/W4388646403.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W2044757050","https://openalex.org/W2046783872","https://openalex.org/W2076398868","https://openalex.org/W2133449490","https://openalex.org/W2145736817"],"related_works":["https://openalex.org/W4412683255","https://openalex.org/W2043875007","https://openalex.org/W2886389978","https://openalex.org/W2070997965","https://openalex.org/W3101108885","https://openalex.org/W2463688823","https://openalex.org/W2011567073","https://openalex.org/W2599103100","https://openalex.org/W2015649564","https://openalex.org/W2376611297"],"abstract_inverted_index":{"Toll-like":[0],"Receptors":[1,9],"(TLRs)":[2],"are":[3,30,66,179,254,349,359,456,495,516],"a":[4,58,102,460,501],"class":[5],"of":[6,12,35,47,61,85,97,109,118,129,140,158,167,193,271,288,311,339,345,374,421,427,453,510,523,561,607,624,649,673],"Pattern":[7],"Recognition":[8],"(PRRs)":[10],"capable":[11],"recognizing":[13],"pathogen-associated":[14],"molecular":[15,21],"patterns":[16,22],"(PAMPs)":[17],"(1)":[18],"and":[19,37,50,74,107,143,148,160,187,196,208,268,377,431,449,462,508,558,566,585,601,640,659,675],"damage-associated":[20],"(DAMPs)":[23],"(2)":[24],"to":[25,44,126,365,405,416,434,444,472,580,681],"initiate":[26],"immune":[27,76,88,121,198,266,279,368,625],"responses.":[28],"TLRs":[29,65,119,159,168,207,218,348,494,632],"crucial":[31],"for":[32,137,145,323,362,493,542,621,656,669],"the":[33,45,69,72,83,95,115,138,156,164,191,203,209,245,258,269,278,337,343,372,419,425,451,488,506,521,532,556,605,619,647,654,670,679],"detection":[34],"infections,":[36],"activating":[38],"downstream":[39],"signaling":[40,235,306,317,423],"pathways":[41],"that":[42,100,225,233,274,304],"lead":[43],"production":[46],"pro-inflammatory":[48],"cytokines":[49],"interferons,":[51],"thereby":[52,189],"initiating":[53],"host":[54,130],"defense":[55,131],"mechanisms":[56,132,557],"against":[57,200,281],"wide":[59],"range":[60],"pathogens":[62],"(3).":[63],"Moreover,":[64],"involved":[67],"in":[68,120,155,169,184,220,244,293,401,424,438,504,531,544,593,635,678],"crosstalk":[70],"between":[71,206],"innate":[73,367],"adaptive":[75,87,197],"systems,":[77],"as":[78,152,182,353,371,498,613,633],"their":[79,262,363,436,590],"activation":[80,108,192,373],"can":[81,382],"influence":[82],"development":[84,139,270,606],"antigenspecific":[86],"responses":[89,199],"(4).":[90],"TLR":[91,177,234,260,316,357,387,422,528,540,583],"ligands":[92],"differentially":[93],"regulate":[94],"function":[96],"dendritic":[98,194,375],"cells":[99,112,195,376],"play":[101],"central":[103],"role":[104,166],"during":[105],"priming":[106],"naive":[110],"T":[111],"(5).":[113],"Understanding":[114],"complex":[116],"interplay":[117,205],"regulation":[122],"not":[123],"only":[124],"contributes":[125],"our":[127],"comprehension":[128],"but":[133],"also":[134,457],"has":[135,212,333],"implications":[136],"vaccines,":[141],"immunotherapies,":[142,188],"treatments":[144,455],"various":[146,562,650],"autoimmune":[147,602],"inflammatory":[149],"disorders":[150],"such":[151,370,612],"cancer.Recent":[153],"developments":[154],"field":[157,464,665],"cancer":[161,170,185,282,295,340,346,407,429,440,466,546,571],"immunity":[162],"underscore":[163],"dual":[165],"development:":[171],"promoting":[172],"or":[173,283,395,616],"inhibiting":[174],"tumor":[175,210,227,242,308,563],"growth.":[176,228],"agonists":[178,358,388,541,615],"being":[180,360],"explored":[181,361],"adjuvants":[183,634],"vaccines":[186],"enhancing":[190],"cancer.":[201],"However,":[202,411],"intricate":[204],"microenvironment":[211],"been":[213],"increasingly":[214],"recognized,":[215],"with":[216,389,637],"some":[217],"implicated":[219],"supporting":[221],"an":[222],"immunosuppressive":[223,285],"milieu":[224],"benefits":[226],"Velasco":[229],"et":[230,301,469,536,551,568],"al.":[231,302,470,537,552,569],"demonstrated":[232],"blockade":[236],"significantly":[237],"decrease":[238],"COPDlike":[239],"inflammation":[240],"dependent":[241],"onset":[243],"lung":[246,250,545],"using":[247],"k-ras":[248],"driven":[249],"adeno-carcinoma":[251],"model":[252],"(6).Researchers":[253],"now":[255],"delving":[256],"into":[257],"specific":[259,481,573],"subtypes,":[261],"differential":[263],"effects":[264,404,448],"on":[265,335,539,555,589],"cells,":[267,380],"TLR-targeted":[272,454,610],"therapies":[273,398],"could":[275],"either":[276],"enhance":[277,406,450],"response":[280],"attenuate":[284],"signals,":[286],"all":[287],"which":[289,381,483],"hold":[290],"significant":[291],"promise":[292,400,668],"advancing":[294],"immunotherapy":[296,674],"strategies":[297,574],"(7).":[298,410,547],"Interestingly,":[299],"Liu":[300],"showed":[303],"LPS":[305],"enhanced":[307],"apoptotic":[309],"activity":[310],"IAP":[312],"targeting":[313,527],"therapy,":[314],"suggesting":[315],"may":[318,644],"use":[319,437,543],"\"synthetic":[320],"lethal\"":[321],"approach":[322],"reducing":[324],"its":[325],"toxicity":[326],"(8).In":[327],"recent":[328],"years":[329,680],"much":[330],"scientific":[331],"interest":[332],"focused":[334],"improving":[336],"efficacy":[338],"immunotherapy.":[341,467,511],"In":[342,512],"realm":[344],"immunotherapy,":[347],"garnering":[350],"increased":[351],"attention":[352],"potential":[354,446,620],"therapeutic":[355,491,661],"targets.":[356],"capacity":[364],"stimulate":[366],"responses,":[369,626],"natural":[378],"killer":[379],"bolster":[383],"antitumor":[384],"immunity.":[385],"Combining":[386],"other":[390],"immunotherapies":[391,639],"like":[392],"checkpoint":[393],"inhibitors":[394],"adoptive":[396],"cell":[397],"holds":[399,666],"creating":[402],"synergistic":[403],"treatment":[408,648],"outcomes":[409],"there":[412,515],"is":[413,578],"ongoing":[414],"research":[415,577],"better":[417],"understand":[418],"nuances":[420],"context":[426],"different":[428],"types":[430,564],"patient":[432],"populations":[433],"optimize":[435],"personalized":[439,641],"immunotherapies.":[441],"Furthermore,":[442],"efforts":[443],"mitigate":[445],"side":[447,629],"specificity":[452],"underway,":[458],"indicating":[459],"dynamic":[461],"evolving":[463,664],"within":[465],"Ota":[468],"tried":[471],"achieve":[473],"efficacy-safety":[474],"margin":[475],"by":[476,526],"utilizing":[477],"small":[478],"molecule":[479],"TLR7":[480],"agonist":[482],"shows":[484],"rapid":[485],"clearance":[486],"from":[487],"body":[489],"(9).The":[490],"prospects":[492],"exceptionally":[496],"promising,":[497],"they":[499],"represent":[500],"critical":[502],"avenue":[503],"both":[505],"understanding":[507],"application":[509,525],"this":[513],"topic":[514],"3":[517],"review":[518],"articles":[519],"discussing":[520],"strategy":[522],"clinical":[524],"signaling,":[529],"especially":[530],"oncology":[533],"field.":[534],"Hoden":[535],"focuses":[538,553],"More":[548],"broadly,":[549],"Yang":[550],"more":[554,608,657],"cutting-edge":[559],"technologies":[560],"(10)":[565],"Mukheerjee":[567],"explores":[570],"type":[572],"(11).":[575],"Ongoing":[576],"likely":[579],"uncover":[581],"novel":[582],"subtypes":[584],"ligands,":[586],"shedding":[587],"light":[588],"nuanced":[591],"roles":[592],"diverse":[594],"disease":[595],"contexts,":[596],"including":[597],"cancer,":[598],"infectious":[599],"diseases,":[600],"disorders.":[603],"Additionally,":[604],"refined":[609],"therapies,":[611],"selective":[614],"antagonists,":[617],"offers":[618],"precise":[622],"modulation":[623],"minimizing":[627],"unwanted":[628],"effects.":[630],"Harnessing":[631],"combination":[636],"emerging":[638],"medicine":[642,677],"approaches":[643],"further":[645],"revolutionize":[646],"conditions,":[651],"ultimately":[652],"paving":[653],"way":[655],"effective":[658],"tailored":[660],"interventions.":[662],"This":[663],"great":[667],"continued":[671],"advancement":[672],"precision":[676],"come.":[682]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-14T00:00:00"}